Crossmark

Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects

Crossref DOI link: https://doi.org/10.1038/s41598-020-57935-6

Published Online: 2020-01-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kawakubo, Mitsuhiro

Tanaka, Miyako

Ochi, Kozue

Watanabe, Akiko

Saka-Tanaka, Marie

Kanamori, Yohei

Yoshioka, Naoki

Yamashita, Satoko

Goto, Moritaka https://orcid.org/0000-0001-5376-4109
Itoh, Michiko

Shirakawa, Ibuki

Kanai, Sayaka

Suzuki, Hiromi

Sawada, Makoto

Ito, Ayaka

Ishigami, Masatoshi

Fujishiro, Mitsuhiro

Arima, Hiroshi

Ogawa, Yoshihiro

Suganami, Takayoshi
Funding

Funding for this research was provided by:

Ministry of Education, Culture, Sports, Science and Technology (18K08508)

Ministry of Education, Culture, Sports, Science and Technology (19K07475)

Hori Sciences and Arts Foundation

Japan Diabetes Society

Takeda Science Foundation
License Information

Text and Data Mining valid from 2020-01-22

Version of Record valid from 2020-01-22
More Information

Article History

Received: 18 September 2019

Accepted: 8 January 2020

First Online: 22 January 2020

Competing interests

: S.T. and M.G. are employees of Sanwa Kagaku Kenkyusho Co., Ltd. The authors declare no further competing interests.

Document is current

Any future updates will be listed below